Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-26T06:21:51.033Z Has data issue: false hasContentIssue false
  • English
  • Français

Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma

Published online by Cambridge University Press:  15 May 2009

D. L. Hahn ,
T. Anttila  and
P. Saikku
D. L. Hahn*
Affiliation:
Dean Medical Center and the Dean Foundation for Health, Research and Education, Madison, Wisconsin, USA
P. Saikku
Affiliation:
National Public Health Institute, Department in Oulu, Finland Department of Microbiology, University of Oulu, Finland
*
* Correspondence and request for reprints: Dr. Hahn, Arcand Park Clinic, 3434 East Washington Avenue., Madison, WI 53704, USA.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

To determine whether recently diagnosed adult–onset asthma is associated with serologic evidence of chronic Chlamydia pneumoniae infection, we performed a case-control study in a primary care clinic of cases with asthma (25 adults reporting first symptoms of asthma within 2 years of enrollment) and 45 concurrently enrolled sex and age (±10 years) matched non-asthmatic controls with normal pulmonary function. C. pneumoniae-specific IgA, IgG and IgG4 antibodies, and circulating immune complexes (CIC) were measured by microimmunofluorescence testing. Results showed that frequencies of IgG litres > 16 (92%), IgG4 litres > 16 (20%) and CIC > 4 (60%) in asthma patients were not significantly different from those of controls. However, asthmatics had a significantly higher prevalence of C. pneumoniae-specific IgA litres > 10 (72% of cases vs 44% of controls, P < 0·05). After adjustment for the effects of age, sex and smoking, the odds ratio for an association of IgA and asthma was 3·7 (95% confidence interval 1·2–11·5). We conclude that recently symptomalic reversible airway obstruction in adults is associated with the presence of C. pneumoniae-specific IgA antibodies, a proposed indicator of chronic respiratory C. pneumoniae infection.

Type
Research Article
Information
Epidemiology & Infection , Volume 117 , Issue 3 , December 1996 , pp. 513 - 517
Copyright
Copyright © Cambridge University Press 1996

References

1.Cookson, JB. Prevalence rates of asthma in developing countries and their comparison with those of Europe and North America. Chest 1987; 91: 97S–103S.CrossRefGoogle ScholarPubMed
2.Burney, P. Epidemiology of asthma. Allergy 1993; 48: 17–23.CrossRefGoogle ScholarPubMed
3.Hahn, DL. Evidence for Chlamydia pneumoniae infection in asthma. In; Allegra, L, Blasi, F, eds. Chlamydia pneumoniae infection. Milan, Italy: Springer-Verlag, 1995: 65–75.CrossRefGoogle ScholarPubMed
4.Tomasi, TB, Grey, HM. Structure and function of immunoglobulin A. Progr Allergy 1972; 16: 81–213.Google ScholarPubMed
5.Sarov, I, Insler, V, Sarov, B et al. Specific serum IgA antibodies in the diagnosis of active viral and chlamydial infections. Proceedings of the European Symposium on New Horizons in Microbiology, Facoltà di Medicina e Chirurgia A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy, Amsterdam: Elsevier Science Publishers, 1984; 157–67.Google Scholar
6.Ekman, M-R, Grayston, JT, Visakorpi, R, Kleemola, M, Kuo, C-c, Saikku, P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17: 420–5.CrossRefGoogle ScholarPubMed
7.von Hertzen, L, Leinonen, M, Surcel, HM, Karjalainen, J, Saikku, P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae. Clin Diagn Lab Immunol 1995; 2: 454–7.CrossRefGoogle ScholarPubMed
8.Hahn, DL, Saikku, P. Serologic evidence for Chlamydia pneumoniae infection in recently symptomatic asthma: a pilot case-control study. Am J Resp Crit Care Med 1995; 151, part 2: A470.Google Scholar
9.American Thoracic Society. Recommended standardized procedures for pulmonary function testing.Am J Resp Dis 1978; 118: 55–77.Google Scholar
10.Wang, S-P, Kuo, C-C, Grayston, JT. Formalinized Chlamydia trachomatis organisms as antigen in the micro-immunofluorescence test. J Clin Microbiol 1979; 10: 259–61.CrossRefGoogle ScholarPubMed
11.Jauhiainen, T, Tuomi, T, Leinonen, M, Kark, JD, Saikku, P. Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations for Chlamydia pneumoniae by microimmunofluorescence test. J Clin Microbiol 1994; 32: 839–40.CrossRefGoogle ScholarPubMed
12.Linnanmäki, E, Leinonen, M, Mattila, K, Nieminen, MS, Valtonen, V, Saikku, P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993; 87: 1130–4.CrossRefGoogle ScholarPubMed
13.Hahn, DL, Dodge, R, Golubjatnikov, R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis and adult-onset asthma. JAMA 1991; 266: 225–30.CrossRefGoogle ScholarPubMed
14.Cunningham, A, Johnston, S, Julious, S, Sillis, M, Ward, ME. The role of Chlamydia pneumoniae and other pathogens in acute episodes of asthma in children. In: Orfila, J et al. , eds. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Chantilly, France, Società Editrice Esculapio, Bologna, Italy, 1994: 480–3.Google Scholar
15.Hukki-Immonen, O, Leinonen, M, Saikku, P. Comparison of local epidemic and TWAR strain in diagnosis of Chlamydia pneumoniae (abstract no. 542). Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, American Society for Microbiology, 1992; 201.Google Scholar
16.Wang, S-P, Grayston, JT. Population prevalence anti-body to Chlamydia pneumoniae, strain TWAR. In: Bowie, WR et al. , eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 402–5.Google Scholar
17.Saikku, P, Leinonen, M, Tenkanen, L et al. , Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273–8.CrossRefGoogle ScholarPubMed
18.Kuo, CC, Grayston, JT, Campbell, LA, Goo, YA, Wissler, RW, Benditt, EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc Natl Acad Sci USA 1995; 92: 6911–4.CrossRefGoogle ScholarPubMed
19.Hahn, DL, Golubjatnikov, R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arteriosclerosis Thrombosis 1992; 12: 945–7.CrossRefGoogle ScholarPubMed
20.Karvonen, M, Tuomilehto, J, Pitkäniemi, J, Naukkarinen, A, Saikku, P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994; 23: 1315–21.CrossRefGoogle ScholarPubMed
21.Falck, G, Heyman, L, Gnarpe, J, Gnarpe, H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scand J Infect Dis 1994; 26: 179–87.CrossRefGoogle ScholarPubMed